|
Post by sluggobear on Feb 2, 2016 20:35:02 GMT -5
Agree with KC. In April, when MNKD gets Afrezza back from SNY, Afrezza must spike in Rx immediately. That will show the street there is promise for the company and SP should come back quickly. How to do that? Yes - maybe just give it away for a while!! I am serious - drastic measures are needed. How to push the reset and make this happen? 1. Communicate to all patients, endos, PCP's in the Rolodex an Afrezza Promise: for all patients currently on Afrezza, or starting Afrezza in 2016, MNKD will ensure uninterrupted supply of Afrezza through 2017 at least. 2. Send out a massive number of samples to PCP's in ONE STATE where Afrezza sales are best, insurance coverage is highest, diabetic numbers are high, and diabetes treatment is solid. Is that state California? 3. The price must be VERY CHEAP for Afrezza. Time frame to lock in six months?
Get people to start using Afrezza and then be able to stay on it...
|
|
|
Post by bradleysbest on Feb 2, 2016 21:23:35 GMT -5
Agree KC as I do not think a 10 day sample is enough to show the benefits of Afrezza! A new fresh approach will help scripts rise.
|
|
|
Post by kc on Feb 2, 2016 21:36:33 GMT -5
Agree KC as I do not think a 10 day sample is enough to show the benefits of Afrezza! A new fresh approach will help scripts rise. I can bet that we have an oversupply of Afrezza already produced. Perhaps the 10 day sample kit and a coupon for the first 30 days of Afrezza which they can pick up the 30 day supply at the local pharmacy. Having fulfillment at the local pharmacy perhaps is a good way for pharmacist to see patients redeeming the coupon for afrezza. It gives more visibility to the pharmacist in knowing what the product is all about. The goal is to get them started as easy as possible. Since we know insurance will still be a problem.
|
|
|
Post by bradleysbest on Feb 2, 2016 21:51:35 GMT -5
Matt said at JPM we have too much inventory at Danbury.... Let's get creative & get the product out!
|
|
|
Post by BlueCat on Feb 3, 2016 12:52:08 GMT -5
It would be interesting to know the complete conversion rates of those sample kits that already went out.
In other words, the problem might not have been enough days. Or enough kits. I think the bigger factors are those already pointed to - e.g. insurance coverage or lack of doctor education to even correctly guide those 10 days. From what people have reported - the users know within a few days if they are having a tough time and wouldn't stick it out to 10 days or more without help?
So - Before using up that supply (which is a significant asset for a company short on cash), the ROI has to be worth it. Solve the right problem.
Seems to me this 100% third-party funded clinic is more on the right track. It is targeting several of the right problems at once:
1. Patient access to Afrezza-open doctors 2. Spirometry 3. Doc education (Doc that gets it, and then generously shares the wealth) 4. Insurance PA assistance/guidance
And I would certainly prioritize making certain these clinics are loaded up with those 10 day paks and coupons before anyone else.
This will serve not only as a near-term incremental revenue opp, but also an all-important POC for crooked wallstreet and potential partners. And with 1-4 in place, I don't think they will need to extend to 30 day trial pak.
Otherwise, use the extra stock to make a few quick sales to another country for short term cash infusion to keep lights on while letting the rest of these longer term strategies come to fruition.
Will be curious to understand this timing issue - open at end of month- but release from SNY not happening til April? Very curious. Maybe they cut a deal on this to exclude these clinics from those terms. Or they are just willing to give away the initial 65% as the clinics will take a few months to get word out and start flying anyway ....
Anyway, that's my non-pharma marketing back-o-napkin GTM. Dying to hear what Matt's got.
Matt/Ray, give us CLOBBERING TIME in T-4.25 hours. Really looking forward to it!
(Yes. I got Ray as The Thing with that great accent. Who is Matt?)
|
|
|
Post by BlueCat on Feb 3, 2016 12:57:02 GMT -5
O, and I will add, advertising, of course. Clinics, sample paks, etc - all going nowhere if no one has even heard of the thing.
And a print ad that looks like its for nicoderm ain't gonna do it.
|
|